2022
DOI: 10.35772/ghm.2022.01051
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes following cholecystectomy in human immunodeficiency virus-positive patients treated with antiretroviral therapy: A retrospective cohort study

Abstract: Patients and Methods PatientsRecords of consecutive HIV-positive patients who underwent cholecystectomy between January 2010 and December 2020 were reviewed retrospectively at the (P1)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…However, in such patients, the presence of an additional comorbidity contraindicates ELC. Particular caution must be observed in patients receiving steroid treatment, immunosuppressive therapy (e.g., transplant recipients), or biological drugs [60][61][62][63]. If laparoscopic cholecystectomy cannot be performed during the primary admission for AC, DLC should be planned after complete clinical recovery and at least 6 weeks after clinical onset [2] (Table 1).…”
Section: Surgery (Cholecystectomy)mentioning
confidence: 99%
“…However, in such patients, the presence of an additional comorbidity contraindicates ELC. Particular caution must be observed in patients receiving steroid treatment, immunosuppressive therapy (e.g., transplant recipients), or biological drugs [60][61][62][63]. If laparoscopic cholecystectomy cannot be performed during the primary admission for AC, DLC should be planned after complete clinical recovery and at least 6 weeks after clinical onset [2] (Table 1).…”
Section: Surgery (Cholecystectomy)mentioning
confidence: 99%